…gene. The kit is said to be ideally suited to high-throughput testing of Covid-19 clinical samples, either with laboratory developed assays or as a component of diagnostic testing kits. According…
…Oxford Biomedica and VMIC are original members of the Oxford University manufacturing consortium focussed on scaling-up the GMP manufacture of the adenovirus vector based COVID-19 vaccine candidate, AZD1222, previously known…
…Covid-19 and Amplidiag Covid-19 molecular diagnostic tests are claimed to be able to rapidly and reliably detect Covid-19 infections at an early stage in patients with signs and symptoms of…
…despite the Covid-19 pandemic. The company said that Part II now contains cohorts of nine different cancers at 1.0 mg/kg dosing and three colorectal cancer (CRC) cohorts at 0.3, 1.0…
Gene and cell therapy group Oxford Biomedica has signed a one-year clinical and commercial supply agreement with AstraZeneca for the manufacture of a Covid-19 vaccine candidate. The agreement relates to…
…alone (p < 0.001). Dr Markku Jalkanen, CEO, Faron, said the publication of these results are crucial and especially important in these times when ICUs are filled with Covid-19 patients,…
…Covid-19. A few responses are listed below. “Covid-19 may be the tipping point that shifts us from the current model of “sick-care” to a more proactive, preventative, participatory and personalised…
…vaccine for both Covid-19 and other viral diseases”, said the biotech specialist, adding that it is moving forward with planned animal testing for its cell-based vaccine platform in Covid-19 and…
…be used. “The threat posed by Covid-19 demands immediate actions to better understand the mechanisms of this virus in humans. We at Creoptix are tremendously excited and proud to support…
The French clinical stage biotechnology company says its ABX464 is the only drug candidate with a potential triple action for Covid-19 treatment; for antiviral, anti-inflammatory and tissue repair. Abivax, a…
U.S. headquartered Neutec Group is providing the laboratory automation required to enable the large-scale output for testing during the current Covid-19 pandemic. Neutec Group said it has been able to…
…UK Biobank to identify genes associated with sepsis, which are also found in severe COVID-19 patients. Sepsis is reported to be observed in 60% of severe Covid-19 patients and is…
…every year from zoonosis, with 75% of new infectious diseases affecting humans coming from animals, such as the recent COVID-19 pandemic”, said Algenex. Dr José Escribano, Founder and CSO of…
…MicronJet microneedle device. According to NanoPass, the aim is to enable the development of a safe, effective and affordable vaccine to help in the fight against COVID-19. The MicronJet microneedle…
…of SARS-CoV-2 (Covid-19) bioreagent research products. Under the terms of the agreement, Sino Biological will provide key bioreagents such as recombinant proteins, antibodies and detection kits for use in Covid-19…
Oxford University and its spin-out company Vaccitech announced an agreement with UK based biopharmaceutical specialist AstraZeneca for the further development, large-scale manufacture and potential distribution of the COVID-19 vaccine candidate,…
